Cstone Pharmaceuticals
Clinical trials sponsored by Cstone Pharmaceuticals, explained in plain language.
-
New hope for lung cancer patients who stopped responding to earlier treatments
Disease control OngoingThis study tests a drug called lorlatinib in about 70 people in China with a specific type of advanced lung cancer (ROS1-positive). Participants had already tried two other treatments (crizotinib and chemotherapy) and their cancer got worse. The goal is to see if lorlatinib can s…
Phase: PHASE2 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 06:09 UTC
-
New hope for liver cancer: drug duo targets tumors without prior therapy
Disease control OngoingThis study tests whether adding nofazinlimab to lenvatinib helps people with advanced liver cancer live longer. About 534 adults who have not had prior systemic treatment will receive either the combo or lenvatinib alone. The main goal is to see if the combination improves overal…
Phase: PHASE3 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated May 19, 2026 11:48 UTC